HCPCS Level II drug code
J2795 — Injection, ropivacaine hydrochloride, 1 mg
In short
J2795 is the HCPCS Level II code for injection, ropivacaine hydrochloride, 1 mg. CMS assigns NDCs for Naropin, Ropivacaine and Ropivacaine HCl to it. One billing unit is 1 mg. The Medicare Part B payment limit is $0.04 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS fileHCPCS codeJ2795
Billing unit1 mg
- Descriptor
- Injection, ropivacaine hydrochloride, 1 mg
- Short descriptor
- Ropivacaine hcl injection
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2001
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP filePayment limit per unit$0.04
Per1 mg
Coinsurance20%
Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 1 mg. For example, 100 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J2795
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 98 NDCs to J2795 for Naropin, Ropivacaine and Ropivacaine HCl. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Naropin | 00404-9924-30 | Henry Schein Inc. | 30 | 150 |
| Naropin | 63323-0285-10 | FreseniUS Kabi USA, LLC | 5 × 10 | 100 |
| Naropin | 63323-0285-13 | FreseniUS Kabi USA, LLC | 25 × 10 | 500 |
| Naropin | 63323-0285-20 | FreseniUS Kabi USA, LLC | 5 × 20 | 200 |
| Naropin | 63323-0285-23 | FreseniUS Kabi USA, LLC | 25 × 20 | 1,000 |
| Naropin | 63323-0285-28 | FreseniUS Kabi USA, LLC | 25 × 20 | 1,000 |
| Naropin | 63323-0285-61 | FreseniUS Kabi USA, LLC | 24 × 100 | 4,800 |
| Naropin | 63323-0285-63 | FreseniUS Kabi USA, LLC | 24 × 200 | 9,600 |
| Naropin | 63323-0285-64 | FreseniUS Kabi USA, LLC | 12 × 200 | 4,800 |
| Naropin | 63323-0285-65 | FreseniUS Kabi USA, LLC | 12 × 100 | 2,400 |
| Naropin | 63323-0285-67 | FreseniUS Kabi USA, LLC | 12 × 100 | 2,400 |
| Naropin | 63323-0285-68 | FreseniUS Kabi USA, LLC | 12 × 100 | 2,400 |
| Naropin | 63323-0285-73 | FreseniUS Kabi USA, LLC | 12 × 200 | 4,800 |
| Naropin | 63323-0286-00 | FreseniUS Kabi USA, LLC | 12 × 100 | 6,000 |
| Naropin | 63323-0286-20 | FreseniUS Kabi USA, LLC | 5 × 20 | 500 |
| Naropin | 63323-0286-23 | FreseniUS Kabi USA, LLC | 25 × 20 | 2,500 |
| Naropin | 63323-0286-27 | FreseniUS Kabi USA, LLC | 25 × 20 | 2,500 |
| Naropin | 63323-0286-35 | FreseniUS Kabi USA, LLC | 25 × 30 | 3,750 |
| Naropin | 63323-0286-38 | FreseniUS Kabi USA, LLC | 25 × 30 | 3,750 |
| Naropin | 63323-0286-63 | FreseniUS Kabi USA, LLC | 12 × 200 | 12,000 |
| Naropin | 63323-0286-95 | FreseniUS Kabi USA, LLC | 25 × 30 | 3,750 |
| Naropin | 63323-0287-20 | FreseniUS Kabi USA, LLC | 5 × 20 | 750 |
| Naropin | 63323-0287-21 | FreseniUS Kabi USA, LLC | 25 × 20 | 3,750 |
| Naropin | 63323-0288-10 | FreseniUS Kabi USA, LLC | 5 × 10 | 500 |
| Naropin | 63323-0288-11 | FreseniUS Kabi USA, LLC | 25 × 10 | 2,500 |
| Naropin | 63323-0288-20 | FreseniUS Kabi USA, LLC | 5 × 20 | 1,000 |
| Naropin | 63323-0288-21 | FreseniUS Kabi USA, LLC | 25 × 20 | 5,000 |
| Naropin | 63323-0288-27 | FreseniUS Kabi USA, LLC | 5 × 20 | 1,000 |
| Naropin | 63323-0288-29 | FreseniUS Kabi USA, LLC | 25 × 20 | 5,000 |
| Ropivacaine | 00143-9263-10 | Hikma Pharmaceuticals USA Inc. | 10 × 20 | 400 |
| Ropivacaine | 25021-0652-82 | Sagent Pharmaceuticals | 10 × 100 | 5,000 |
| Ropivacaine | 25021-0652-87 | Sagent Pharmaceuticals | 10 × 200 | 10,000 |
| Ropivacaine | 25021-0671-66 | Sagent Pharmaceuticals | 10 × 100 | 2,000 |
| Ropivacaine | 25021-0671-67 | Sagent Pharmaceuticals | 10 × 200 | 4,000 |
| Ropivacaine | 25021-0671-82 | Sagent Pharmaceuticals | 10 × 100 | 2,000 |
| Ropivacaine | 25021-0671-87 | Sagent Pharmaceuticals | 10 × 200 | 4,000 |
| Ropivacaine | 43066-0015-10 | Baxter Healthcare Corporation | 10 × 20 | 400 |
| Ropivacaine | 43066-0019-10 | Baxter Healthcare Corporation | 10 × 20 | 1,000 |
| Ropivacaine | 43066-0023-10 | Baxter Healthcare Corporation | 10 × 30 | 1,500 |
| Ropivacaine | 43066-0027-10 | Baxter Healthcare Corporation | 10 × 20 | 2,000 |
| Ropivacaine | 43066-0152-10 | Baxter Healthcare Corporation | 10 × 100 | 2,000 |
| Ropivacaine | 43066-0154-10 | Baxter Healthcare Corporation | 10 × 200 | 4,000 |
| Ropivacaine | 55150-0195-20 | Eugia US LLC | 25 × 20 | 1,000 |
| Ropivacaine | 55150-0196-99 | Eugia US LLC | 100 | 200 |
| Ropivacaine | 55150-0197-20 | Eugia US LLC | 25 × 20 | 2,500 |
| Ropivacaine | 55150-0198-30 | Eugia US LLC | 25 × 30 | 3,750 |
| Ropivacaine | 55150-0199-20 | Eugia US LLC | 25 × 20 | 3,750 |
| Ropivacaine | 55150-0200-10 | Eugia US LLC | 25 × 10 | 2,500 |
| Ropivacaine | 55150-0201-20 | Eugia US LLC | 25 × 20 | 5,000 |
| Ropivacaine HCl | 00143-9195-24 | Hikma Pharmaceuticals USA Inc. | 24 × 100 | 4,800 |
| Ropivacaine HCl | 00143-9264-10 | Hikma Pharmaceuticals USA Inc. | 10 × 30 | 1,500 |
| Ropivacaine HCl | 00143-9265-10 | Hikma Pharmaceuticals USA Inc. | 10 × 20 | 1,500 |
| Ropivacaine HCl | 00143-9266-10 | Hikma Pharmaceuticals USA Inc. | 10 × 20 | 2,000 |
| Ropivacaine HCl | 52584-0286-35 | Henry Schein Inc. | 30 | 150 |
| Ropivacaine HCl | 65145-0107-10 | Caplin Steriles USA Inc. | 10 × 20 | 400 |
| Ropivacaine HCl | 65145-0108-10 | Caplin Steriles USA Inc. | 10 × 20 | 1,000 |
| Ropivacaine HCl | 65145-0109-10 | Caplin Steriles USA Inc. | 10 × 30 | 1,500 |
| Ropivacaine HCl | 65145-0110-10 | Caplin Steriles USA Inc. | 10 × 20 | 2,000 |
| Ropivacaine HCl | 65145-0165-01 | Caplin Steriles USA Inc. | 100 | 200 |
| Ropivacaine HCl | 65145-0165-10 | Caplin Steriles USA Inc. | 10 × 100 | 2,000 |
Showing 60 of 98. The full list is in the CMS crosswalk file.
J2795: common questions
- Is J2795 a CPT code?
- No. J2795 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J2795?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 98 NDCs under J2795, for Naropin, Ropivacaine and Ropivacaine HCl. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J2795?
- $0.04 per 1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J2795?
- One unit of J2795 is 1 mg, as stated in the code's descriptor. Units to report = dose given ÷ 1 mg. J-code billing units.